VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces its subsidiary Urban Juve has received positive national media attention from two of Canada’s leading lifestyle magazines […]
Tarrytown, NY, Apr 10, 2019 — Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, recently received notice from the US Trademark Office that all requirements have been satisfied for registration […]
Beauty and Wellness Experience for Successful Global Brands, Creativity, and Strategic Acumen Determined the Successful Agency Selection VANCOUVER, British Columbia, April 04, 2019 – The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces The Design […]
VANCOUVER, Washington, Apr 04, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that […]
CNN: Dangerous bacteria and fungi lurk in some commercial soils, leading to harmful infections and even death CORONA, Calif., April 4, 2019 /GP Solutions (OTC: GWPD) the developer of GrowPod modular automated micro-farms, announced that its […]
Product line will heighten company’s presence in $262 billion organic food market CORONA, Calif., March 19, 2019 – GP Solutions (OTC: GWPD) owner of Grow Pod Solutions, a leading developer of modular automated micro-farms, has partnered with […]
Tarrytown, NY, Apr 01, 2019 — Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced today that Nightfood unaudited quarterly revenues surpassed $150,000 for the first time in Company […]
Tarrytown, NY, Mar 29, 2019 – Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced today that their second production run has been completed of all eight flavors of […]
New data suggests that 525 mg dose and 700 mg dose responders’ rates are approximately 90% for those HIV patients who pass first 10 weeks of monotherapy without virologic failure CytoDyn has engaged top CCR5 […]
DENVER, March 29, 2019 – Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, today announced that the Company will present at the Spring Investor Summit being held […]
Tarrytown, NY, March 21, 2019 — Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, continues to capture the attention of the market with two major national media outlets featuring Nightfood […]
FDA Previously Granted Rolling Review for BLA VANCOUVER, Washington, Mar 18, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential […]
DENVER, March 21, 2019 -Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, today announced it will be presenting at the Sidoti & Company, LLC, Spring 2019 […]
VANCOUVER, Washington, March 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that leronlimab (PRO 140), […]
Tarrytown, NY, March 11, 2019 — Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced that the second production run of Nightfood ice cream will begin this week, and […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
